Anti-CTLA-4 monoclonal antibodies
What are Anti-CTLA-4 monoclonal antibodies?
Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. Anti-CTLA-4 monoclonal antibodies are directed to the inhibitory receptor CD152 (CTLA-4). They may be use to treat certain types of melanoma.
List of Anti-CTLA-4 monoclonal antibodies
View by Generic | Brand
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| ipilimumab systemic (Pro) Brand name: Yervoy |
5 reviews | |
| tremelimumab systemic (Pro) Brand name: Imjudo | No reviews | |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
See also
Medical conditions treated or associated with anti-CTLA-4 monoclonal antibodies:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.